Search hospitals > Utah > Provo
Utah Valley Regional Medical Center
Claim this profileProvo, Utah 84604
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Stomach Cancer
Conducts research for Prostate Cancer
258 reported clinical trials
12 medical researchers
Summary
Utah Valley Regional Medical Center is a medical facility located in Provo, Utah. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer and other specialties. Utah Valley Regional Medical Center is involved with conducting 258 clinical trials across 375 conditions. There are 12 research doctors associated with this hospital, such as Nicholas DiBella, Ramya Thota, Vilija N. Avizonis, and Grant K. Hunter.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Nicholas DiBellaRocky Mountain Cancer Centers-Boulder6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
103 reported clinical trials
193 drugs studied
Ramya ThotaIntermountain Medical Center8 years of reported clinical research
Studies Colon Cancer
Studies Colorectal Cancer
5 reported clinical trials
28 drugs studied
Vilija N. AvizonisIntermountain Medical Center11 years of reported clinical research
Studies Skin Cancer
Studies Squamous Cell Carcinoma
4 reported clinical trials
11 drugs studied
Grant K. HunterUtah Valley Regional Medical Center3 years of reported clinical research
Studies Brain Tumor
Studies Gliomas
4 reported clinical trials
9 drugs studied
Clinical Trials running at Utah Valley Regional Medical Center
Prostate Cancer
Lung Cancer
Bladder Cancer
Breast Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Multiple Myeloma
Prostate Adenocarcinoma
Squamous Cell Carcinoma
Oropharyngeal Cancer
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting2 awards Phase 310 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Utah Valley Regional Medical Center?
Utah Valley Regional Medical Center is a medical facility located in Provo, Utah. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Prostate Cancer and other specialties. Utah Valley Regional Medical Center is involved with conducting 258 clinical trials across 375 conditions. There are 12 research doctors associated with this hospital, such as Nicholas DiBella, Ramya Thota, Vilija N. Avizonis, and Grant K. Hunter.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.